Basic Information
Basic information for LINC00662-241-20aa
Peptide Name LINC00662-241-20aa
Genome Position chr19:27746131-27746190[-]
Species Human
Peptide Sequence MSGSPPAGVCPADPDSTTDE
Peptide Length 20
Unique No (LINC00662-207-20aa,LINC00662-210-20aa,LINC00662-212-20aa,LINC00662-213-20aa,LINC00662-214-20aa-1,LINC00662-215-20aa,LINC00662-216-20aa,LINC00662-217-20aa,LINC00662-219-20aa-2,LINC00662-220-20aa,LINC00662-221-20aa-1,LINC00662-222-20aa-1,LINC00662-223-20aa-1,LINC00662-224-20aa-2,LINC00662-225-20aa-1,LINC00662-227-20aa,LINC00662-230-20aa-4,LINC00662-231-20aa-3,LINC00662-232-20aa-1,LINC00662-233-20aa,LINC00662-235-20aa,LINC00662-239-20aa-2,LINC00662-240-20aa-1,LINC00662-242-20aa-2,LINC00662-244-20aa,LINC00662-245-20aa-4,LINC00662-247-20aa-2,LINC00662-249-20aa,LINC00662-251-20aa,LINC00662-252-20aa,LINC00662-253-20aa-2,LINC00662-254-20aa,LINC00662-256-20aa,LINC00662-257-20aa-4,LINC00662-258-20aa,LINC00662-259-20aa,LINC00662-260-20aa,LINC00662-261-20aa-1,LINC00662-262-20aa-1,LINC00662-264-20aa,LINC00662-265-20aa,LINC00662-267-20aa,LINC00662-268-20aa-1,LINC00662-269-20aa,LINC00662-270-20aa-2,LINC00662-271-20aa,LINC00662-272-20aa,LINC00662-273-20aa-1,LINC00662-274-20aa,LINC00662-275-20aa,LINC00662-277-20aa)
Grand Average of Hydropathicity -0.64
Relative Molecular Mass 2276.38
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000659922;LINC00662-241
Transcript Length 1410
Coding Ability 0.266
DNA Sequence Corresponding to Peptide ATGTCGGGGTCACCACCTGCGGGGGTTTGTCCTGCAGACCCTGACTCAACGACGGATGAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :